期刊文献+

(S)-1-苄基-3-羟基吡咯烷的合成及红外光谱研究

FTIR Study on the Reduction of 1-Benzyl-3-Hydroxypyrrolidine-2,5-Dione
下载PDF
导出
摘要 从L-苹果酸出发,经过与苄胺缩合反应得到(S)-1-苄基-3-羟基吡咯烷-2,5-二酮,再通过硼氢化钠-碘体系还原制得重要的医药中间体(S)-1-苄基-3-羟基吡咯烷。采用红外光谱法对原料、中间体及产物进行了测试并对硼氢化钠-碘体系还原酰亚胺的机理进行了研究。通过比较原料、中间体及产物相应特征吸收峰的消失或是出现,可知所得的产物为(S)-1-苄基-3-羟基吡咯烷;还原机理研究表明,硼氢化钠在碘催化下生成的硼烷与酰亚胺中的羰基形成四元环状过渡态,同时另外一分子硼烷与酰亚胺中的氮原子形成N-BH3复合物,然后羰基还原完全,得到(S)-1-苄基-3-羟基吡咯烷-硼烷复合物,最后在甲醇作用下脱去硼烷得到最终产物。 The title compound was synthesized by reducing(S)-1-benzyl-3-hydroxypyrrolidine-2,5-dione with sodium borohydride-iodin.The raw material,intermediate,and the end product were characterized by IR spectra and the mechanism of reduction of imide by sodium borohydride-iodin was also studied by IR spectra.According to the IR spectra,it was concluded that the product was(S)-1-bezyl-3-hydroxypyrrolidine.The mechanism of the reduction is that borane,formed in situ by reacting sodium borohydride with iodine,partly was conjugated to carbonyl to form four-member-ring intermediate and partly conjugated to nitrogen.(S)-1-benzyl-3-hydroxypyrrolidine/BH3 complex was gained when the reduction finished.The title compound was obtained by removing borane from the complex in methanol.
作者 魏林 邱飞
出处 《光谱学与光谱分析》 SCIE EI CAS CSCD 北大核心 2012年第5期1238-1240,共3页 Spectroscopy and Spectral Analysis
基金 国家自然科学基金项目(30900351) 福建省自然科学基金项目(2009J05029) 福建省生物医药工程研究生教育创新基地项目(06070205))资助
关键词 红外光谱 机理 (S)-1-苄基-3-羟基吡咯烷 硼氢化钠-碘 FTIR spectra Mechanism (S)-1-benzyl-3-hydroxypyrrolidine Sodium borohydride-iodin
  • 相关文献

参考文献13

  • 1Cross P E,Mackenzie A R.US Patent,5096890,1992.
  • 2王丽,陈国华.盐酸巴尼地平的合成[J].化工时刊,2007,21(6):27-29. 被引量:5
  • 3阳舒波,王涛,李宝山,等.China Patent,101468962A,2007.
  • 4魏林,陆晨熠,邱飞.熔融法合成(S)-1-苄基-3羟基吡咯烷-2,5-二酮[J].精细化工中间体,2011,41(1):27-28. 被引量:2
  • 5Walker E R H.Chem.Soc.Rev.,1976,5:23.
  • 6Brown H C,Weissman P M,Yoon N M.J.Am.Chem.Soc.,1966,88:1458.
  • 7Donohue A C,Jackson W R.Aust.J.Chem.,1995,48(10):1741.
  • 8Irvine G J,Lesley M J G,Marder T B,et al.Chem.Rev.,1998,98(8):2625.
  • 9Abiko A,Masamune S.Tetrahedron Lett.,1992,33(38):5517.
  • 10Yamakawa T,Masaki M,Nohira H.Bull.Chem.Soc.Jpn.,1991,64:2730.

二级参考文献14

  • 1杨贯羽,宋延林,嵇耀武,黄志新.1,4-二氢吡啶类化合物的合成[J].郑州大学学报(自然科学版),1996,28(2):86-89. 被引量:9
  • 2王丽,陈国华.盐酸巴尼地平的合成[J].化工时刊,2007,21(6):27-29. 被引量:5
  • 3Cross P E, Mackenzie A R. Pyrrolidine derivatives: US, 5096890[P]. 1992-03-17.
  • 4阳舒波,王涛,李宝山,等.制备(S)-2,2-苯基-2-(3-吡咯烷基)乙酰胺的方法:中国,101468962A[P].2009-07-01.
  • 5Kazuharu T, Hideki A, Tadao K, et al. Stereoselectivity of a potent calcium antagonist, 1-benzyl-3-pyrrolidinyl methyl 2,6 -dimethy1-4 - ( m -nitrophenyl ) - 1,4 -dihydropyridine -3,5 - dicarboxylate[J]. J Med Chem, 1986, 29:2 504-2 511.
  • 6Crishna L B, Denise M F, Madeleine M J. Synthetic routs to chiral 3-pyrrolidinols [J]. Synth Commun, 1985, 15(7): 587-598.
  • 7Naylor A, Judd D B, Scopesd I C, et al. 4-[(Alkylamino) methyllfuro [3,2-e]pyridines: a new series of selective kappa-receptor agonists[J ]. J Med Chem, 1994, 37 (14) : 2 138-2 144.
  • 8Tadao Kojima,Toiehi Takenaka.1,4-Dihydropyridine-3,5-Dicarboxylic Acid Ester Derivatives[P].US 4221649,1980-09-02
  • 9Kazuharu Tamazawa,Tadao Kojima,Hideki Arima,el al.Dihydropyridine-3,5-dicarboxylie acid ester derivative isomers,their preparation,and pharmaceutical compositions containing them[P].EP 0160451,1985-11-06
  • 10Kazuharu Tamazawa,Hideki Arima,Tadao K@ma.,et al.Stereoselectivity of a Potent Calcium hntagonist,1-Benzyl-3-pyrrolidinyl Methyl 2,6-Dimethyl-4-(m-nitrophenyl)-1,4-dihydro-pyridine-3,5-dicarboxylate[J].Journal of Medlcinal Chemistry,1986,29(12):2504~2511

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部